Skip to main content

Canton Barry's Form 4 filing

Ginkgo Bioworks Holdings, Inc. (DNA) · filed Nov 22, 2022

Accession no.
0000899243-22-036787
Filed
Nov 22, 2022
Trade date
Nov 18-21, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions. Open-market sales total $863.6K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Canton BarryCIK 000188275610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 18, 2022Class A Common StockSSaleDisposed−98,562$2.17−$213,879.5420,623,669DirectDuplicate filing
Nov 18, 2022Class A Common StockSSaleDisposed−98,562$2.17−$213,879.5420,623,667IndirectDuplicate filing
Nov 21, 2022Class A Common StockSSaleDisposed−103,765$2.10−$217,906.520,519,904DirectDuplicate filing
Nov 21, 2022Class A Common StockSSaleDisposed−103,764$2.10−$217,904.420,519,903IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)